Essential thrombocythemia and primary myelofibrosis DC 7718
Essential thrombocythemia and primary myelofibrosis VA Disability Rating Details
| Diagnostic Code | 7718 |
|---|---|
| Category | The Hemic and Lymphatic Systems |
| Subcategory | The Hematologic and Lymphatic Systems |
| Also Known As | Essential thrombocythemia and primary myelofibrosis |
| CFR Section | 4.117 |
Next Steps for This Condition
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment |
| 70% | Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 × 10 9 /L |
| 30% | Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count of 200,000-400,000, or white blood cell (WBC) count of 4,000-10,000 |
| 0% | Asymptomatic |